Pharma Industry Regulatory Challenges
Pharmaceutical companies to establish the testing, patenting, safety, and efficacy in development process govern the law and regulations with trackers or validators so to promote safe and better health while ensuring the best practices are put forward.
Drugs are in various stages of lifecycle (development, yet-to-be-marketed and global expansion), Pharma companies and their Regulatory Affairs departments face challenges in the context of CMC and Regulatory activities aligning with market standards for necessary drug registrations, approvals and compliant market-entry.
The challenges include:
Tracking down various region-specific HA regulations pertaining to
- Quality and Assurance
- GxP Practices
- Audit and Validation
- Lifecycle Management
- Pharma CMC
- Dossier Compilation
Pharmaceutical Regulatory Affairs Procedural Complexities
- Publishing and Submission
- Dossier Preparation
- Labeling, Artwork Design and Pack Management
- Medical Writing